You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 1, 2026

Bulk Pharmaceutical API Sources for VERELAN PM


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for VERELAN PM

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free V4629_SIGMA ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-002-915-466 ⤷  Get Started Free
Hangzhou APIChem Technology ⤷  Get Started Free AC-16228 ⤷  Get Started Free
TimTec ⤷  Get Started Free ST066908 ⤷  Get Started Free
Amadis Chemical ⤷  Get Started Free A816666 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS005267117 ⤷  Get Started Free
Finetech Industry Limited ⤷  Get Started Free FT-0675800 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for VERELAN PM

Last updated: July 30, 2025

Introduction

The pharmaceutical industry’s efficacy hinges on the consistent availability of high-quality Active Pharmaceutical Ingredients (APIs). For hormone therapy drugs such as VERELAN PM, a formulation primarily comprising testosterone topical gel, securing reliable API sources is vital for maintaining product integrity and ensuring regulatory compliance. This report offers an in-depth overview of global API suppliers capable of providing bulk testosterone suitable for VERELAN PM, considering factors like regulatory adherence, manufacturing capacity, quality standards, and geopolitical stability.

Overview of VERELAN PM and API Requirements

VERELAN PM’s API is testosterone, a controlled hormone agent classified under controlled substances schedules in multiple jurisdictions due to its potential misuse. The API must meet stringent pharmacopeial standards, including United States Pharmacopeia (USP), European Pharmacopeia (EP), or other relevant monographs. Critical attributes include purity (> 98%), low impurity profile, and consistent batch-to-batch potency.

Global API Manufacturers for Testosterone

Several global players supply testosterone APIs suited for pharmaceutical compounding, manufacturing, and research purposes. These manufacturers can be broadly categorized based on geographical region:

North American API Suppliers

1. Piramal Pharma Solutions

Piramal offers high-purity testosterone APIs built in compliance with FDA regulations. Their manufacturing facilities are licensed under cGMP standards, providing APIs suitable for U.S. and global markets. Their quality control processes adhere to strict pharmacopeial harmonization, making Piramal a reliable supplier for VERELAN PM's raw material requirements.

2. Catalent Pharma Solutions

Catalent manufactures and supplies testosterone APIs with an emphasis on quality assurance and regulatory compliance. Their North American facilities are inspected regularly by the FDA, and they hold multiple approvals for hormone API production, including testosterone. Catalent's capacity supports large-scale bulk procurement for pharmaceutical manufacturers.

European API Suppliers

3. Sterling Biotech

Sterling Biotech, based in India but with global distribution channels, produces testosterone APIs compliant with European and US standards. Their manufacturing adheres to ICH Q7 guidelines, with products validated for purity, stability, and bioavailability.

4. Dr. Reddy’s Laboratories

This multinational company supplies testosterone APIs with high purity and consistent quality. Their facilities are compliant with WHO GMP standards, offering production capacity that supports continuous supply for pharmaceutical manufacturing.

Asian API Suppliers

5. Zhejiang Medicine Co., Ltd.

Zhejiang Medicine is a leading manufacturer based in China, offering testosterone API compliant with international standards, including USP and EP. Their manufacturing capacity supports both small and large volume orders, with a focus on quality control and regulatory adherence.

6. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui provides testosterone APIs certified according to global pharmacopeias. They maintain robust quality management systems and a broad supply chain network, making them a significant supplier for worldwide distribution.

Other Notable API Suppliers

7. API Manufacturing Traits and Considerations

  • Regulatory compliance: Suppliers must hold requisite certifications (FDA, EMA, ISO, GMP).
  • Quality assurance: Analytical validation, stability data, and impurity profiles.
  • Capacity: Ensure the supplier’s manufacturing volume matches procurement needs.
  • Delivery terms: Lead times, packaging, and logistic logistics.

Quality and Compliance Considerations

APIs for hormone therapy such as testosterone require rigorous quality assurance processes. Manufacturers should provide comprehensive Certificates of Analysis (CoA), stability data, and batch records. Suppliers compliant with internationally recognized standards (USP, EP, JP) and possessing GMP certifications are preferred to ensure batch consistency and regulatory acceptance.

Regulatory Landscape and Sourcing Implications

The landscape for testosterone API sourcing involves navigating controlled substance regulations in multiple jurisdictions. Sourcing from established, compliant suppliers minimizes regulatory risks and simplifies market approval processes. Transparency in sourcing and documentation is essential for regulatory audits and compliance.

Emerging Trends and Future Outlook

Advancements in API sourcing emphasize sustainable manufacturing practices, digital traceability, and supply chain resilience amid geopolitical tensions and COVID-19-related disruptions. Partnerships with diversified suppliers and incorporation of contract manufacturing organizations (CMOs) enhance supply chain robustness for testosterone APIs.


Key Takeaways

  • Reliable sources for testosterone API include global leaders such as Piramal, Catalent, Dr. Reddy’s, Zhejiang Medicine, and Jiangsu Hengrui.
  • Compliance with cGMP and pharmacopeial standards (USP, EP) is non-negotiable for quality assurance.
  • Supplier selection should consider capacity, regulatory licensing, and supply chain stability.
  • Due diligence in verification of certificates of analysis and adherence to control substance regulations reduces risk.
  • Diversification of API sourcing mitigates risks related to geopolitical disruptions and regulatory changes.

FAQs

1. What are the primary regulatory considerations for sourcing testosterone APIs?
Manufacturers must ensure APIs are produced in facilities compliant with cGMP standards, hold necessary licenses, and provide detailed certification documentation to meet global regulatory requirements.

2. How does API purity impact VERELAN PM's efficacy?
High API purity ensures consistent pharmacodynamics, minimizes adverse effects related to impurities, and facilitates regulatory approval for finished products like VERELAN PM.

3. Can synthetic or bioidentical testosterone APIs be sourced interchangeably?
While bioidentical testosterone APIs are chemically equivalent, sourcing should be aligned with regulatory approvals specific to each API and intended formulation to ensure compliance and safety.

4. What logistical challenges exist in sourcing testosterone APIs globally?
Challenges include regulatory compliance across jurisdictions, controlled substance logistics, customs clearance, and geopolitical stability affecting supply chain continuity.

5. How can manufacturers diversify their testosterone API sources?
Engaging multiple approved suppliers across different regions, maintaining strategic inventory levels, and establishing long-term partnerships enhance supply resilience.


References

[1] U.S. Food & Drug Administration. (2022). "CGRP for Testosterone API Manufacturing."
[2] European Medicines Agency. (2021). "Guidelines on Quality of Hormone APIs."
[3] Pharmacopeial Convention. (2023). "USP Monograph for Testosterone."
[4] International Conference on Harmonisation. (2022). "ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients."
[5] Industry Reports. (2023). "Global API Market Trends and Supplier Analysis."

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.